# Concomitant Tricuspid Repair in Patients With Left Heart Surgery

Study · id `cardio:ct-nct05595187` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05595187](<https://clinicaltrials.gov/study/NCT05595187>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05595187

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.

## Technical summary

Registry record NCT05595187. Randomized; double masking; primary purpose treatment. Start 2024-05-01 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT05595187, source copy `cardio:ctgov-nct05595187-2023-12-14`, retrieved 2026-10-26)
- Planned start: 2024-05-01 (anticipated) (ClinicalTrials.gov record NCT05595187, source copy `cardio:ctgov-nct05595187-2023-12-14`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT05595187, source copy `cardio:ctgov-nct05595187-2023-12-14`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT05595187, source copy `cardio:ctgov-nct05595187-2023-12-14`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05595187, source copy `cardio:ctgov-nct05595187-2023-12-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05595187-2023-12-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Concomitant Tricuspid Repair in Patients With Left Heart Surgery
- Condition: Tricuspid Regurgitation
- Condition: Mitral Regurgitation
- Condition: Cardiopulmonary Bypass
- Intervention (Device): Tricuspid repair
- Lead sponsor: Nanjing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)
- Registry lists this organization as the lead sponsor: Nanjing Medical University (`cardio:org-nanjing-medical-university`)

## Provenance

Content hash: 0c0748e363b1ad9d99fd683f5debbab6d20e326d83c311a60fde8e0f985eb655
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
